"德诺沃"心力衰竭中功能轨迹与减少喷射分数:对结果的影响
Oscar Otero Garcia1, Víctor Donoso Trenado2, Pablo de la Fuente-López1
1Cardiology Department, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Open heart
|February 6, 2026
概括
在因心力衰竭而住院的患者中,射率降低 (HFrEF),排放时功能恶化预测结果较差. 然而,在随访期间,稳定或改善的功能与更好的预后和生存有关.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床医学 临床医学
背景情况:
- 心力衰竭 (HF) 和慢性病 (CKD) 经常同时存在,显著恶化患者的预后.
- 由于新发性心力衰竭而住院的患者减少排气分数 (HFrEF) 是功能影响结果的脆弱人群.
研究的目的:
- 为了调查新生HFrEF入院患者的功能轨迹.
- 评估这些功能变化对主要临床结果的影响,包括死亡率和HF再入院.
主要方法:
- 一项前性队列研究,涉及住院患者 de novo HFrEF.
- 使用CKD-流行病学协作 (CKD-EPI) 公式评估估计的淋巴细胞过率 (eGFR) 的功能.
- 在随访期间评估总死亡率和综合死亡率以及HF再入院率.
主要成果:
- 在出院时,24.6%的患者的eGFR<45mL/min/1.73m2;更高的eGFR与更好的结果相关.
- 在随访期间,79.1%的患者保持或改善了EGFR (≥45毫升/分钟/1.73米2).
- 稳定或改善的eGFR患者的总死亡率和HF再入院率显著降低. 有利于脏改善的因素包括较少的前科CKD,高血压,年轻年龄,更高的EGFR排出量和四倍治疗使用.
结论:
- 在 de novo HFrEF 患者出院时功能恶化与不良临床结果相关.
- 在随访期间,功能稳定或改善与更好的预后有关.
- 常规功能评估对于个性化HFrEF管理至关重要,指导干预措施以预防衰退和改善患者护理.
更多相关视频
07:49A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models
Published on: July 21, 2023
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
相关概念视频
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...